30 July 2024
Viruses | Selected Papers in the Section “Viral Immunology, Vaccines, and Antivirals”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “The Inhibition of Gag-Pol Expression by the Restriction Factor Shiftless Is Dispensable for the Restriction of HIV-1 Infection”
by Niklas Jäger, Shreya Ahana Ayyub, Frank Peske, David Liedtke, Jens Bohne, Markus Hoffmann, Marina V. Rodnina and Stefan Pöhlmann
Viruses 2024, 16(4), 583; https://doi.org/10.3390/v16040583
Available online: https://www.mdpi.com/1999-4915/16/4/583

2. “Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors”
by Andreia Costa-Tuna, Otávio A. Chaves, Zaida L. Almeida, Rita S. Cunha, João Pina and Carlos Serpa
Viruses 2024, 16(4), 491; https://doi.org/10.3390/v16040491
Available online: https://www.mdpi.com/1999-4915/16/4/491

3. “Gene-Editing and RNA Interference in Treating Hepatitis B: A Review”
by Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, Andreea Bretcan, Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Robert Flisiak and Piotr Rzymski
Viruses 2023, 15(12), 2395; https://doi.org/10.3390/v15122395
Available online: https://www.mdpi.com/1999-4915/15/12/2395

4. “G-Quadruplexes in the Viral Genome: Unlocking Targets for Therapeutic Interventions and Antiviral Strategies”
by Rajiv Pathak
Viruses 2023, 15(11), 2216; https://doi.org/10.3390/v15112216
Available online: https://www.mdpi.com/1999-4915/15/11/2216

5. “Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library”
by Isra M. Alsaady, Leena H. Bajrai, Thamir A. Alandijany, Hattan S. Gattan, Mai M. El-Daly, Sarah A. Altwaim, Rahaf T. Alqawas, Vivek Dhar Dwivedi and Esam I. Azhar
Viruses 2023, 15(8), 1739; https://doi.org/10.3390/v15081739
Available online: https://www.mdpi.com/1999-4915/15/8/1739

6. “Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein”
by Leidy Lorena García-Ariza, Natalia González-Rivillas, Cindy Johanna Díaz-Aguirre, Cristian Rocha-Roa, Leonardo Padilla-Sanabria and Jhon Carlos Castaño-Osorio
Viruses 2023, 15(7), 1563; https://doi.org/10.3390/v15071563
Available online: https://www.mdpi.com/1999-4915/15/7/1563

7. “Investigating the Mechanism of Action of Anti-Dengue Compounds as Potential Binders of Zika Virus RNA-Dependent RNA Polymerase”
by Thamir A. Alandijany, Mai M. El-Daly, Ahmed M. Tolah, Leena H. Bajrai, Aiah M. Khateb, Isra M. Alsaady, Sarah A. Altwaim, Amit Dubey, Vivek Dhar Dwivedi and Esam I. Azhar
Viruses 2023, 15(7), 1501; https://doi.org/10.3390/v15071501
Available online: https://www.mdpi.com/1999-4915/15/7/1501

8. “SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies”
by Nina Reuter, Xiaohan Chen, Barbara Kropff, Antonia Sophia Peter, William J. Britt, Michael Mach, Klaus Überla and Marco Thomas
Viruses 2023, 15(7), 1500; https://doi.org/10.3390/v15071500
Available online: https://www.mdpi.com/1999-4915/15/7/1500